Pepsi and Netflix Kick Off Second-Quarter Earnings Season
We also have big names in finance and healthcare on our radar.
We also have big names in finance and healthcare on our radar.
As the second quarter ends, another season of earnings begins with a report from PepsiCo (PEP) on Monday, followed by reports from Johnson & Johnson (JNJ) and Netflix (NFLX) on Thursday. We also expect to see earnings reports from financial-services giants on Tuesday and Thursday, and BlackRock (BLK) closes the week with its report on Friday.
Snacks have become a haven for consumers during the pandemic and quarantine, leaving companies like PepsiCo in a better position than others. During the market turbulence, the wide-moat company has been able to focus on its strategic priorities.
As a leader across the major healthcare industries, Johnson & Johnson continues to present the next generation of drugs to treat unmet medical conditions. The wide-moat firm is well-positioned in immunology and continues to report strong data in oncology.
Netlfix's subscriber growth took off at the start of 2020 as the coronavirus outbreak gained momentum and people stayed home. However, the narrow-moat firm has more subscribers outside of the United States than inside, and we believe that maintaining subscribers in the U.S. will continue to be a challenge for Netflix.
Citigroup (C), JPMorgan Chase (JPM), and Wells Fargo (WFC) are expected to report earnings on Tuesday. We are looking out for Bank of America's (BAC) earnings on Thursday, and an earnings report from BlackRock, which has felt the weight of the pressure to reopen local economies, is expected on Friday.
Carole Hodorowicz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.